Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate

Abstract Background The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide. There is increasing evidence that GDM is a heterogeneous disease with different subtypes. An important question in this context is whether impaired glucose tolerance (IGT), which is a typical feature o...

Full description

Bibliographic Details
Main Authors: Moritz Liebmann, Katharina Grupe, Melissa Asuaje Pfeifer, Ingo Rustenbeck, Stephan Scherneck
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Lipids in Health and Disease
Subjects:
Online Access:https://doi.org/10.1186/s12944-022-01706-x
_version_ 1828106114140471296
author Moritz Liebmann
Katharina Grupe
Melissa Asuaje Pfeifer
Ingo Rustenbeck
Stephan Scherneck
author_facet Moritz Liebmann
Katharina Grupe
Melissa Asuaje Pfeifer
Ingo Rustenbeck
Stephan Scherneck
author_sort Moritz Liebmann
collection DOAJ
description Abstract Background The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide. There is increasing evidence that GDM is a heterogeneous disease with different subtypes. An important question in this context is whether impaired glucose tolerance (IGT), which is a typical feature of the disease, may already be present before pregnancy and manifestation of the disease. The latter type resembles in its clinical manifestation prediabetes that has not yet manifested as type 2 diabetes (T2DM). Altered lipid metabolism plays a crucial role in the disorder's pathophysiology. The aim was to investigate the role of lipids which are relevant in diabetes-like phenotypes in these both models with different time of initial onset of IGT. Methods Two rodent models reflecting different characteristics of human GDM were used to characterize changes in lipid metabolism occurring during gestation. Since the New Zealand obese (NZO)-mice already exhibit IGT before and during gestation, they served as a subtype model for GDM with preexisting IGT (preIGT) and were compared with C57BL/6 N mice with transient IGT acquired during gestation (aqIGT). While the latter model does not develop manifest diabetes even under metabolic stress conditions, the NZO mouse is prone to severe disease progression later in life. Metabolically healthy Naval Medical Research Institute (NMRI) mice served as controls. Results In contrast to the aqIGT model, preIGT mice showed hyperlipidemia during gestation with elevated free fatty acids (FFA), triglycerides (TG), and increased atherogenic index. Interestingly, sphingomyelin (SM) concentrations in the liver decreased during gestation concomitantly with an increase in the sphingosine-1-phosphate (S1P) concentration in plasma. Further, preIGT mice showed impaired hepatic weight adjustment and alterations in hepatic FFA metabolism during gestation. This was accompanied by decreased expression of peroxisome proliferator-activated receptor alpha (PPARα) and lack of translocation of fatty acid translocase (FAT/CD36) to the hepatocellular plasma membrane. Conclusion The preIGT model showed impaired lipid metabolism both in plasma and liver, as well as features of insulin resistance consistent with increased S1P concentrations, and in these characteristics, the preIGT model differs from the common GDM subtype with aqIGT. Thus, concomitantly elevated plasma FFA and S1P concentrations, in addition to general shifts in sphingolipid fractions, could be an interesting signal that the metabolic disorder existed before gestation and that future pregnancies require more intensive monitoring to avoid complications. Graphical Abstract This graphical abstract was created with BioRender.com .
first_indexed 2024-04-11T10:11:28Z
format Article
id doaj.art-271ad5d37edf402dbe025e4857485891
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-04-11T10:11:28Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-271ad5d37edf402dbe025e48574858912022-12-22T04:30:04ZengBMCLipids in Health and Disease1476-511X2022-10-0121112110.1186/s12944-022-01706-xDifferences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphateMoritz Liebmann0Katharina Grupe1Melissa Asuaje Pfeifer2Ingo Rustenbeck3Stephan Scherneck4Institute of Pharmacology, Toxicology and Clinical Pharmacy, Technische Universität BraunschweigInstitute of Pharmacology, Toxicology and Clinical Pharmacy, Technische Universität BraunschweigInstitute of Pharmacology, Toxicology and Clinical Pharmacy, Technische Universität BraunschweigInstitute of Pharmacology, Toxicology and Clinical Pharmacy, Technische Universität BraunschweigInstitute of Pharmacology, Toxicology and Clinical Pharmacy, Technische Universität BraunschweigAbstract Background The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide. There is increasing evidence that GDM is a heterogeneous disease with different subtypes. An important question in this context is whether impaired glucose tolerance (IGT), which is a typical feature of the disease, may already be present before pregnancy and manifestation of the disease. The latter type resembles in its clinical manifestation prediabetes that has not yet manifested as type 2 diabetes (T2DM). Altered lipid metabolism plays a crucial role in the disorder's pathophysiology. The aim was to investigate the role of lipids which are relevant in diabetes-like phenotypes in these both models with different time of initial onset of IGT. Methods Two rodent models reflecting different characteristics of human GDM were used to characterize changes in lipid metabolism occurring during gestation. Since the New Zealand obese (NZO)-mice already exhibit IGT before and during gestation, they served as a subtype model for GDM with preexisting IGT (preIGT) and were compared with C57BL/6 N mice with transient IGT acquired during gestation (aqIGT). While the latter model does not develop manifest diabetes even under metabolic stress conditions, the NZO mouse is prone to severe disease progression later in life. Metabolically healthy Naval Medical Research Institute (NMRI) mice served as controls. Results In contrast to the aqIGT model, preIGT mice showed hyperlipidemia during gestation with elevated free fatty acids (FFA), triglycerides (TG), and increased atherogenic index. Interestingly, sphingomyelin (SM) concentrations in the liver decreased during gestation concomitantly with an increase in the sphingosine-1-phosphate (S1P) concentration in plasma. Further, preIGT mice showed impaired hepatic weight adjustment and alterations in hepatic FFA metabolism during gestation. This was accompanied by decreased expression of peroxisome proliferator-activated receptor alpha (PPARα) and lack of translocation of fatty acid translocase (FAT/CD36) to the hepatocellular plasma membrane. Conclusion The preIGT model showed impaired lipid metabolism both in plasma and liver, as well as features of insulin resistance consistent with increased S1P concentrations, and in these characteristics, the preIGT model differs from the common GDM subtype with aqIGT. Thus, concomitantly elevated plasma FFA and S1P concentrations, in addition to general shifts in sphingolipid fractions, could be an interesting signal that the metabolic disorder existed before gestation and that future pregnancies require more intensive monitoring to avoid complications. Graphical Abstract This graphical abstract was created with BioRender.com .https://doi.org/10.1186/s12944-022-01706-xGestational diabetes mellitus (GDM)PrediabetesSubpopulationsHeterogeneity of GDMSphingolipidsSphingosine-1-phosphate
spellingShingle Moritz Liebmann
Katharina Grupe
Melissa Asuaje Pfeifer
Ingo Rustenbeck
Stephan Scherneck
Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate
Lipids in Health and Disease
Gestational diabetes mellitus (GDM)
Prediabetes
Subpopulations
Heterogeneity of GDM
Sphingolipids
Sphingosine-1-phosphate
title Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate
title_full Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate
title_fullStr Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate
title_full_unstemmed Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate
title_short Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate
title_sort differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation role of free fatty acids and sphingosine 1 phosphate
topic Gestational diabetes mellitus (GDM)
Prediabetes
Subpopulations
Heterogeneity of GDM
Sphingolipids
Sphingosine-1-phosphate
url https://doi.org/10.1186/s12944-022-01706-x
work_keys_str_mv AT moritzliebmann differencesinlipidmetabolisminacquiredversuspreexistingglucoseintoleranceduringgestationroleoffreefattyacidsandsphingosine1phosphate
AT katharinagrupe differencesinlipidmetabolisminacquiredversuspreexistingglucoseintoleranceduringgestationroleoffreefattyacidsandsphingosine1phosphate
AT melissaasuajepfeifer differencesinlipidmetabolisminacquiredversuspreexistingglucoseintoleranceduringgestationroleoffreefattyacidsandsphingosine1phosphate
AT ingorustenbeck differencesinlipidmetabolisminacquiredversuspreexistingglucoseintoleranceduringgestationroleoffreefattyacidsandsphingosine1phosphate
AT stephanscherneck differencesinlipidmetabolisminacquiredversuspreexistingglucoseintoleranceduringgestationroleoffreefattyacidsandsphingosine1phosphate